{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:18:36Z","timestamp":1787689116152,"version":"build-2784847793"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T00:00:00Z","timestamp":1506902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T00:00:00Z","timestamp":1506902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Protective antibody levels are critical for protection from severe enterovirus 71 infection. However, little is known about the specificities and functional properties of the enterovirus 71-specific antibodies induced by natural infection in humans. Here we characterize 191 plasmablast-derived monoclonal antibodies from three enterovirus 71-infected children, each of whom shows a distinct serological response. Of the 84 enterovirus 71-specific antibodies, neutralizing antibodies that target the rims and floor of the capsid canyon exhibit broad and potent activities at the nanogram level against viruses isolated in 1998\u20132016. We also find a subset of infected children whose enterovirus 71-specific antibodies are focused on the 3- and 2-fold plateau epitopes localized at the margin of pentamers, and this type of antibody response is associated with lower serum titers against recently circulating strains. Our data provide new insights into the enterovirus 71-specific antibodies induced by natural infection at the serological and clonal levels.<\/jats:p>","DOI":"10.1038\/s41467-017-00736-9","type":"journal-article","created":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T15:54:42Z","timestamp":1506441282000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6891-6945","authenticated-orcid":false,"given":"Kuan-Ying","family":"Arthur Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yhu-Chering","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Ru","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsun","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jainn-Jim","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Ren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chien","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzou-Yien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,2]]},"reference":[{"key":"736_CR1","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1086\/338819","volume":"34","author":"TY Lin","year":"2002","unstructured":"Lin, T. Y. et al. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin. Infect. Dis. \n                           34(Suppl 2): S52\u2013S57 (2002).","journal-title":"Clin. Infect. Dis."},{"key":"736_CR2","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.3201\/eid1812.120929","volume":"18","author":"TH Khanh","year":"2012","unstructured":"Khanh, T. H. et al. Enterovirus 71-associated hand, foot, and mouth disease, Southern Vietnam, 2011. Emerg. Infect. Dis. \n                           18, 2002\u20132005 (2012).","journal-title":"Emerg. Infect. Dis."},{"key":"736_CR3","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2014.19.38.20911","volume":"19","author":"TK Fischer","year":"2014","unstructured":"Fischer, T. K. et al. Emergence of enterovirus 71 C4a in Denmark, 2009 to 2013. Euro. Surveill. \n                           19, pii 20911 (2014).","journal-title":"Euro. Surveill."},{"key":"736_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S1473-3099(13)70342-6","volume":"14","author":"W Xing","year":"2014","unstructured":"Xing, W. et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect. Dis. \n                           14, 308\u2013318 (2014).","journal-title":"Lancet Infect. Dis."},{"key":"736_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116322","volume":"10","author":"ST Luo","year":"2015","unstructured":"Luo, S. T. et al. Reemergence of enterovirus 71 epidemic in northern Taiwan, 2012. PLoS ONE \n                           10, e0116322 (2015).","journal-title":"PLoS ONE"},{"key":"736_CR6","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1128\/JCM.00630-09","volume":"47","author":"SW Huang","year":"2009","unstructured":"Huang, S. W. et al. Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. J. Clin. Microbiol. \n                           47, 3653\u20133662 (2009).","journal-title":"J. Clin. Microbiol."},{"key":"736_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.coviro.2012.02.009","volume":"2","author":"PC McMinn","year":"2012","unstructured":"McMinn, P. C. Recent advances in the molecular epidemiology and control of human enterovirus 71 infection. Curr. Opin. Virol \n                           2, 199\u2013205 (2012).","journal-title":"Curr. Opin. Virol"},{"key":"736_CR8","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1128\/JVI.01019-09","volume":"84","author":"KK Tee","year":"2010","unstructured":"Tee, K. K. et al. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J. Virol. \n                           84, 3339\u20133350 (2010).","journal-title":"J. Virol."},{"key":"736_CR9","doi-asserted-by":"crossref","first-page":"9969","DOI":"10.1128\/JVI.73.12.9969-9975.1999","volume":"73","author":"BA Brown","year":"1999","unstructured":"Brown, B. A., Oberste, M. S., Alexander, J. P. Jr, Kennett, M. L. & Pallansch, M. A. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J. Virol. \n                           73, 9969\u20139975 (1999).","journal-title":"J. Virol."},{"key":"736_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-6-74","volume":"6","author":"C Yoke-Fun","year":"2006","unstructured":"Yoke-Fun, C. & AbuBakar, S. Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus 71 subgenotypes. BMC Microbiol. \n                           6, 74 (2006).","journal-title":"BMC Microbiol."},{"key":"736_CR11","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1128\/JCM.00628-08","volume":"46","author":"JM Bible","year":"2008","unstructured":"Bible, J. M. et al. Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006. J. Clin. Microbiol. \n                           46, 3192\u20133200 (2008).","journal-title":"J. Clin. Microbiol."},{"key":"736_CR12","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s00705-010-0722-0","volume":"155","author":"CC Yip","year":"2010","unstructured":"Yip, C. C. et al. Emergence of enterovirus 71 \u201cdouble-recombinant\u201d strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV71. Arch. Virol. \n                           155, 1413\u20131424 (2010).","journal-title":"Arch. Virol."},{"key":"736_CR13","doi-asserted-by":"publisher","DOI":"10.1542\/peds.109.6.e88","volume":"109","author":"LY Chang","year":"2002","unstructured":"Chang, L. Y. et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease\/herpangina in children during an epidemic in Taiwan. Pediatrics \n                           109, e88 (2002).","journal-title":"Pediatrics"},{"key":"736_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-21-16","volume":"21","author":"P Linsuwanon","year":"2014","unstructured":"Linsuwanon, P. et al. Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations. J. Biomed. Sci. \n                           21, 16 (2014).","journal-title":"J. Biomed. Sci."},{"key":"736_CR15","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/infdis\/jiv094","volume":"212","author":"KY Huang","year":"2015","unstructured":"Huang, K. Y. et al. A potent virus-specific antibody-secreting cell response to acute enterovirus 71 infection in Children. J. Infect. Dis. \n                           212, 808\u2013817 (2015).","journal-title":"J. Infect. Dis."},{"key":"736_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002067","volume":"7","author":"ML Huang","year":"2013","unstructured":"Huang, M. L. et al. Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development. PLoS Negl. Trop. Dis. \n                           7, e2067 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"736_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079783","volume":"8","author":"AH Chou","year":"2013","unstructured":"Chou, A. H. et al. Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers. PLoS ONE \n                           8, e79783 (2013).","journal-title":"PLoS ONE"},{"key":"736_CR18","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3201\/eid2209.151579","volume":"22","author":"SM van der Sanden","year":"2016","unstructured":"van der Sanden, S. M. et al. Prediction of protection against Asian Enterovirus 71 outbreak strains by cross-neutralizing capacity of Serum from Dutch donors, The Netherlands. Emerg. Infect. Dis. \n                           22, 1562\u20131569 (2016).","journal-title":"Emerg. Infect. Dis."},{"key":"736_CR19","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1172\/JCI81104","volume":"125","author":"KY Huang","year":"2015","unstructured":"Huang, K. Y. et al. Focused antibody response to influenza linked to antigenic drift. J. Clin. Invest. \n                           125, 2631\u20132645 (2015).","journal-title":"J. Clin. Invest."},{"key":"736_CR20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature01470","volume":"422","author":"X Wei","year":"2003","unstructured":"Wei, X. et al. Antibody neutralization and escape by HIV-1. Nature \n                           422, 307\u2013312 (2003).","journal-title":"Nature"},{"key":"736_CR21","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1084\/jem.20090766","volume":"207","author":"S Fafi-Kremer","year":"2010","unstructured":"Fafi-Kremer, S. et al. Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation. J. Exp. Med. \n                           207, 2019\u20132031 (2010).","journal-title":"J. Exp. Med."},{"key":"736_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.vaccine.2012.10.032","volume":"31","author":"Y Chen","year":"2013","unstructured":"Chen, Y. et al. Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity. Vaccine \n                           31, 425\u2013430 (2013).","journal-title":"Vaccine"},{"key":"736_CR23","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1056\/NEJMp1400601","volume":"370","author":"PC McMinn","year":"2014","unstructured":"McMinn, P. C. Enterovirus vaccines for an emerging cause of brain-stem encephalitis. N. Engl. J. Med. \n                           370, 792\u2013794 (2014).","journal-title":"N. Engl. J. Med."},{"key":"736_CR24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nsmb.2255","volume":"19","author":"X Wang","year":"2012","unstructured":"Wang, X. et al. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat. Struct. Mol. Biol. \n                           19, 424\u2013429 (2012).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"736_CR25","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1073\/pnas.1222379110","volume":"110","author":"P Plevka","year":"2013","unstructured":"Plevka, P. et al. Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc. Natl. Acad. Sci. USA \n                           110, 5463\u20135467 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"736_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jviromet.2011.02.003","volume":"173","author":"HW Chang","year":"2011","unstructured":"Chang, H. W. et al. Generation of murine monoclonal antibodies which cross-neutralize human enterovirus genogroup B isolates. J. Virol. Methods \n                           173, 189\u2013195 (2011).","journal-title":"J. Virol. Methods"},{"key":"736_CR27","doi-asserted-by":"publisher","first-page":"12084","DOI":"10.1128\/JVI.02189-15","volume":"89","author":"Z Ku","year":"2015","unstructured":"Ku, Z. et al. Single neutralizing monoclonal antibodies targeting the VP1 GH loop of enterovirus 71 inhibit both virus attachment and internalization during viral entry. J. Virol. \n                           89, 12084\u201312095 (2015).","journal-title":"J. Virol."},{"key":"736_CR28","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.bbrc.2009.09.103","volume":"390","author":"X Li","year":"2009","unstructured":"Li, X. et al. Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides. Biochem. Biophys. Res. Commun. \n                           390, 1126\u20131128 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"736_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029751","volume":"7","author":"XF Lim","year":"2012","unstructured":"Lim, X. F. et al. Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection. PLoS ONE \n                           7, e29751 (2012).","journal-title":"PLoS ONE"},{"key":"736_CR30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.7150\/thno.7457","volume":"4","author":"L Xu","year":"2014","unstructured":"Xu, L. et al. Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop. Theranostics \n                           4, 498\u2013513 (2014).","journal-title":"Theranostics"},{"key":"736_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002895","volume":"8","author":"TK Kiener","year":"2014","unstructured":"Kiener, T. K., Jia, Q., Meng, T., Chow, V. T. & Kwang, J. A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved \u201cknob\u201d region of VP3 protein. PLoS Negl. Trop. Dis. \n                           8, e2895 (2014).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"736_CR32","doi-asserted-by":"publisher","first-page":"11363","DOI":"10.1128\/JVI.01926-13","volume":"87","author":"H Lee","year":"2013","unstructured":"Lee, H. et al. A strain-specific epitope of enterovirus 71 identified by cryo-electron microscopy of the complex with fab from neutralizing antibody. J. Virol. \n                           87, 11363\u201311370 (2013).","journal-title":"J. Virol."},{"key":"736_CR33","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature13764","volume":"516","author":"L Pappas","year":"2014","unstructured":"Pappas, L. et al. Rapid development of broadly influenza neutralizing antibodies through redundant mutations. Nature \n                           516, 418\u2013422 (2014).","journal-title":"Nature"},{"key":"736_CR34","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.4049\/jimmunol.174.6.3454","volume":"174","author":"JH Weitkamp","year":"2005","unstructured":"Weitkamp, J. H. et al. VH1-46 is the dominant immunoglobulin heavy chain gene segment in rotavirus-specific memory B cells expressing the intestinal homing receptor alpha4beta7. J. Immunol. \n                           174, 3454\u20133460 (2005).","journal-title":"J. Immunol."},{"key":"736_CR35","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.molimm.2008.09.005","volume":"46","author":"MK Gorny","year":"2009","unstructured":"Gorny, M. K. et al. Preferential use of the VH5\u201351 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1. Mol. Immunol. \n                           46, 917\u2013926 (2009).","journal-title":"Mol. Immunol."},{"key":"736_CR36","doi-asserted-by":"publisher","first-page":"11500","DOI":"10.1128\/JVI.02035-15","volume":"89","author":"SW Huang","year":"2015","unstructured":"Huang, S. W. et al. Mapping enterovirus A71 antigenic determinants from viral evolution. J. Virol. \n                           89, 11500\u201311506 (2015).","journal-title":"J. Virol."},{"key":"736_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1126\/science.1178746","volume":"326","author":"LM Walker","year":"2009","unstructured":"Walker, L. M. et al. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science \n                           326, 285\u2013289 (2009).","journal-title":"Science"},{"key":"736_CR38","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1205669","volume":"333","author":"D Corti","year":"2011","unstructured":"Corti, D. et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science \n                           333, 850\u2013856 (2011).","journal-title":"Science"},{"key":"736_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaj1879","volume":"1","author":"MS Gilman","year":"2016","unstructured":"Gilman, M. S. et al. Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors. Sci. Immunol. \n                           1, eaaj1879 (2016).","journal-title":"Sci. Immunol."},{"key":"736_CR40","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nature06890","volume":"453","author":"J Wrammert","year":"2008","unstructured":"Wrammert, J. et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature \n                           453, 667\u2013671 (2008).","journal-title":"Nature"},{"key":"736_CR41","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1128\/JVI.03203-15","volume":"90","author":"L Priyamvada","year":"2016","unstructured":"Priyamvada, L. et al. B cell responses during secondary dengue virus infection are dominated by highly cross-reactive, memory-derived plasmablasts. J. Virol. \n                           90, 5574\u20135585 (2016).","journal-title":"J. Virol."},{"key":"736_CR42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF02918417","volume":"2","author":"JA Berzofsky","year":"1983","unstructured":"Berzofsky, J. A. T-B reciprocity. An Ia-restricted epitope-specific circuit regulating T cell-B cell interaction and antibody specificity. Surv. Immunol. Res. \n                           2, 223\u2013229 (1983).","journal-title":"Surv. Immunol. Res."},{"key":"736_CR43","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nature13300","volume":"509","author":"AD Gitlin","year":"2014","unstructured":"Gitlin, A. D., Shulman, Z. & Nussenzweig, M. C. Clonal selection in the germinal centre by regulated proliferation and hypermutation. Nature \n                           509, 637\u2013640 (2014).","journal-title":"Nature"},{"key":"736_CR44","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1084\/jem.20141404","volume":"211","author":"NT Pauli","year":"2014","unstructured":"Pauli, N. T. et al. Staphylococcus aureus infection induces protein A-mediated immune evasion in humans. J. Exp. Med. \n                           211, 2331\u20132339 (2014).","journal-title":"J. Exp. Med."},{"key":"736_CR45","doi-asserted-by":"publisher","first-page":"8701","DOI":"10.1073\/pnas.0903427106","volume":"106","author":"W Ndifon","year":"2009","unstructured":"Ndifon, W., Wingreen, N. S. & Levin, S. A. Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines. Proc. Natl Acad. Sci. USA \n                           106, 8701\u20138706 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"736_CR46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.immuni.2013.04.012","volume":"39","author":"T Zhou","year":"2013","unstructured":"Zhou, T. et al. Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies. Immunity \n                           39, 245\u2013258 (2013).","journal-title":"Immunity"},{"key":"736_CR47","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/jama.280.6.527","volume":"280","author":"HA Gans","year":"1998","unstructured":"Gans, H. A. et al. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA \n                           280, 527\u2013532 (1998).","journal-title":"JAMA"},{"key":"736_CR48","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.1016\/j.vaccine.2014.05.038","volume":"32","author":"CJ Sande","year":"2014","unstructured":"Sande, C. J., Cane, P. A. & Nokes, D. J. The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants. Vaccine \n                           32, 4726\u20134729 (2014).","journal-title":"Vaccine"},{"key":"736_CR49","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.2014.3085","volume":"282","author":"AK Simon","year":"2015","unstructured":"Simon, A. K., Hollander, G. A. & McMichael, A. Evolution of the immune system in humans from infancy to old age. Proc. Biol. Sci. \n                           282, 20143085 (2015).","journal-title":"Proc. Biol. Sci."},{"key":"736_CR50","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3285","volume":"12","author":"PC Wilson","year":"2012","unstructured":"Wilson, P. C. & Andrews, S. F. Tools to therapeutically harness the human antibody response. Nat. Rev. Immunol. \n                           12, 709\u2013719 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"736_CR51","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1126\/science.1076071","volume":"298","author":"NL Bernasconi","year":"2002","unstructured":"Bernasconi, N. L., Traggiai, E. & Lanzavecchia, A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science \n                           298, 2199\u20132202 (2002).","journal-title":"Science"},{"key":"736_CR52","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.0105-2896.2006.00402.x","volume":"211","author":"RM Zinkernagel","year":"2006","unstructured":"Zinkernagel, R. M. & Hengartner, H. Protective \u2018immunity\u2019 by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called \u2018immunological memory\u2019. Immunol. Rev. \n                           211, 310\u2013319 (2006).","journal-title":"Immunol. Rev."},{"key":"736_CR53","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1056\/NEJMoa066092","volume":"357","author":"IJ Amanna","year":"2007","unstructured":"Amanna, I. J., Carlson, N. E. & Slifka, M. K. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. \n                           357, 1903\u20131915 (2007).","journal-title":"N. Engl. J. Med."},{"key":"736_CR54","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.chom.2014.05.013","volume":"16","author":"KJ Jackson","year":"2014","unstructured":"Jackson, K. J. et al. Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. Cell Host Microbe \n                           16, 105\u2013114 (2014).","journal-title":"Cell Host Microbe"},{"key":"736_CR55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.virol.2016.11.009","volume":"501","author":"CW Tan","year":"2016","unstructured":"Tan, C. W., Sam, I. C., Lee, V. S., Wong, H. V. & Chan, Y. F. VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction. Virology \n                           501, 79\u201387 (2016).","journal-title":"Virology"},{"key":"736_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003511","volume":"9","author":"Y Nishimura","year":"2013","unstructured":"Nishimura, Y. et al. Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathog. \n                           9, e1003511 (2013).","journal-title":"PLoS Pathog."},{"key":"736_CR57","doi-asserted-by":"publisher","first-page":"6406","DOI":"10.1074\/jbc.M111.301622","volume":"287","author":"P Chen","year":"2012","unstructured":"Chen, P. et al. Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J. Biol. Chem. \n                           287, 6406\u20136420 (2012).","journal-title":"J. Biol. Chem."},{"key":"736_CR58","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1128\/JVI.02070-12","volume":"87","author":"S Yamayoshi","year":"2013","unstructured":"Yamayoshi, S., Ohka, S., Fujii, K. & Koike, S. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J. Virol. \n                           87, 3335\u20133347 (2013).","journal-title":"J. Virol."},{"key":"736_CR59","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1128\/JVI.03098-14","volume":"89","author":"KL Shingler","year":"2015","unstructured":"Shingler, K. L. et al. The enterovirus 71 procapsid binds neutralizing antibodies and rescues virus infection in vitro. J. Virol. \n                           89, 1900\u20131908 (2015).","journal-title":"J. Virol."},{"key":"736_CR60","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s13238-014-0087-3","volume":"5","author":"M Dang","year":"2014","unstructured":"Dang, M. et al. Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell \n                           5, 692\u2013703 (2014).","journal-title":"Protein Cell"},{"key":"736_CR61","doi-asserted-by":"crossref","first-page":"14587","DOI":"10.1016\/S0021-9258(18)63732-9","volume":"264","author":"MG Rossmann","year":"1989","unstructured":"Rossmann, M. G. The canyon hypothesis. Hiding the host cell receptor attachment site on a viral surface from immune surveillance. J. Biol. Chem. \n                           264, 14587\u201314590 (1989).","journal-title":"J. Biol. Chem."},{"key":"736_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-6-141","volume":"6","author":"B Yang","year":"2009","unstructured":"Yang, B., Chuang, H. & Yang, K. D. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol. J. \n                           6, 141 (2009).","journal-title":"Virol. J."},{"key":"736_CR63","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1073\/pnas.1320624111","volume":"111","author":"P Plevka","year":"2014","unstructured":"Plevka, P. et al. Neutralizing antibodies can initiate genome release from human enterovirus 71. Proc. Natl Acad. Sci. USA \n                           111, 2134\u20132139 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"736_CR64","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1073\/pnas.1616502114","volume":"114","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. Potent neutralization of hepatitis A virus reveals a receptor mimic mechanism and the receptor recognition site. Proc. Natl Acad. Sci. USA \n                           114, 770\u2013775 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"736_CR65","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jaip.2015.12.015","volume":"4","author":"D Bearden","year":"2016","unstructured":"Bearden, D., Collett, M., Quan, P. L., Costa-Carvalho, B. T. & Sullivan, K. E. Enteroviruses in X-linked Agammaglobulinemia: update on epidemiology and therapy. J. Allergy Clin. Immunol. Pract. \n                           4, 1059\u20131065 (2016).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"736_CR66","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/emmm.201303404","volume":"6","author":"G Fibriansah","year":"2014","unstructured":"Fibriansah, G. et al. A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface. EMBO Mol. Med. \n                           6, 358\u2013371 (2014).","journal-title":"EMBO Mol. Med."},{"key":"736_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003240","volume":"9","author":"KL Shingler","year":"2013","unstructured":"Shingler, K. L. et al. The enterovirus 71 A-particle forms a gateway to allow genome release: a cryoEM study of picornavirus uncoating. PLoS Pathog. \n                           9, e1003240 (2013).","journal-title":"PLoS Pathog."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00736-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00736-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00736-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T21:07:13Z","timestamp":1671743233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00736-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,2]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["736"],"URL":"https:\/\/doi.org\/10.1038\/s41467-017-00736-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,2]]},"assertion":[{"value":"22 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"762"}}